176 related articles for article (PubMed ID: 26088748)
1. Estimating the risk of chemotherapy toxicity in older patients with cancer: The role of the Vulnerable Elders Survey-13 (VES-13).
Luciani A; Biganzoli L; Colloca G; Falci C; Castagneto B; Floriani I; Battisti N; Dottorini L; Ferrari D; Fiduccia P; Zafarana E; Del Monte F; Galli F; Monfardini S; Foa P
J Geriatr Oncol; 2015 Jul; 6(4):272-9. PubMed ID: 26088748
[TBL] [Abstract][Full Text] [Related]
2. [Cancer treatment in elderly patients: evidence and clinical research].
Repetto L; Luciani A
Recenti Prog Med; 2015 Jan; 106(1):23-7. PubMed ID: 25621776
[TBL] [Abstract][Full Text] [Related]
3. A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation.
Mohile SG; Bylow K; Dale W; Dignam J; Martin K; Petrylak DP; Stadler WM; Rodin M
Cancer; 2007 Feb; 109(4):802-10. PubMed ID: 17219443
[TBL] [Abstract][Full Text] [Related]
4. Can Vulnerable Elders Survey-13 predict the impact of frailty on chemotherapy in elderly patients with gynaecological malignancies?
Ferrero A; Villa M; Tripodi E; Fuso L; Menato G
Medicine (Baltimore); 2018 Sep; 97(39):e12298. PubMed ID: 30278504
[TBL] [Abstract][Full Text] [Related]
5. Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13.
Luciani A; Ascione G; Bertuzzi C; Marussi D; Codecà C; Di Maria G; Caldiera SE; Floriani I; Zonato S; Ferrari D; Foa P
J Clin Oncol; 2010 Apr; 28(12):2046-50. PubMed ID: 20308657
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy.
Aaldriks AA; Maartense E; le Cessie S; Giltay EJ; Verlaan HA; van der Geest LG; Kloosterman-Boele WM; Peters-Dijkshoorn MT; Blansjaar BA; van Schaick HW; Nortier JW
Crit Rev Oncol Hematol; 2011 Aug; 79(2):205-12. PubMed ID: 20709565
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the CARG tool, the VES-13, and oncologist judgment in predicting grade 3+ toxicities in men undergoing chemotherapy for metastatic prostate cancer.
Alibhai SM; Aziz S; Manokumar T; Timilshina N; Breunis H
J Geriatr Oncol; 2017 Jan; 8(1):31-36. PubMed ID: 27756545
[TBL] [Abstract][Full Text] [Related]
8. Vulnerable Elderly Survey 13 as a screening method for frailty in Polish elderly surgical patient--prospective study.
Kenig J; Richter P; Zychiewicz B; Olszewska U
Pol Przegl Chir; 2014 Mar; 86(3):126-31. PubMed ID: 24791815
[TBL] [Abstract][Full Text] [Related]
9. A Questionnaire Study to Assess the Value of the Vulnerable Elders Survey, G8, and Predictors of Toxicity as Screening Tools for Frailty and Toxicity in Geriatric Cancer Patients.
Hentschel L; Rentsch A; Lenz F; Hornemann B; Schmitt J; Baumann M; Ehninger G; Schuler M
Oncol Res Treat; 2016; 39(4):210-6. PubMed ID: 27160741
[TBL] [Abstract][Full Text] [Related]
10. Performance of the Vulnerable Elders Survey 13 screening tool in identifying cancer treatment modification after geriatric assessment in pre-treatment patients: A retrospective analysis.
Rowbottom L; Loucks A; Jin R; Breunis H; Syed AT; Watt S; Timilshina N; Puts M; Yokom D; Berger A; Alibhai SMH
J Geriatr Oncol; 2019 Mar; 10(2):229-234. PubMed ID: 30420323
[TBL] [Abstract][Full Text] [Related]
11. Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' group.
Hamaker ME; Seynaeve C; Wymenga AN; van Tinteren H; Nortier JW; Maartense E; de Graaf H; de Jongh FE; Braun JJ; Los M; Schrama JG; van Leeuwen-Stok AE; de Groot SM; Smorenburg CH
Breast; 2014 Feb; 23(1):81-7. PubMed ID: 24314824
[TBL] [Abstract][Full Text] [Related]
12. Completion of radiotherapy is associated with the Vulnerable Elders Survey-13 score in elderly patients with cancer.
Spyropoulou D; Pallis AG; Leotsinidis M; Kardamakis D
J Geriatr Oncol; 2014 Jan; 5(1):20-5. PubMed ID: 24484714
[TBL] [Abstract][Full Text] [Related]
13. PPT and VES-13 in elderly patients with cancer: evaluation in multidimensional geriatric assessment and prediction of survival.
Augschoell J; Kemmler G; Hamaker ME; Stauder R
J Geriatr Oncol; 2014 Oct; 5(4):415-21. PubMed ID: 25242575
[TBL] [Abstract][Full Text] [Related]
14. Prospective comparison of the value of CARG, G8, and VES-13 toxicity tools in predicting chemotherapy-related toxicity in older Turkish patients with cancer.
Cavdar E; Iriagac Y; Karaboyun K; Avci O; Seber ES
J Geriatr Oncol; 2022 Jul; 13(6):821-827. PubMed ID: 35361561
[TBL] [Abstract][Full Text] [Related]
15. Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.
Soubeyran P; Bellera C; Goyard J; Heitz D; Curé H; Rousselot H; Albrand G; Servent V; Jean OS; van Praagh I; Kurtz JE; Périn S; Verhaeghe JL; Terret C; Desauw C; Girre V; Mertens C; Mathoulin-Pélissier S; Rainfray M
PLoS One; 2014; 9(12):e115060. PubMed ID: 25503576
[TBL] [Abstract][Full Text] [Related]
16. Functional decline in older patients with cancer receiving first-line chemotherapy.
Hoppe S; Rainfray M; Fonck M; Hoppenreys L; Blanc JF; Ceccaldi J; Mertens C; Blanc-Bisson C; Imbert Y; Cany L; Vogt L; Dauba J; Houédé N; Bellera CA; Floquet A; Fabry MN; Ravaud A; Chakiba C; Mathoulin-Pélissier S; Soubeyran P
J Clin Oncol; 2013 Nov; 31(31):3877-82. PubMed ID: 24062399
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive geriatric assessment in female elderly patients with Alzheimer disease and other types of dementia.
Riccio D; Solinas A; Astara G; Mantovani G
Arch Gerontol Geriatr; 2007; 44 Suppl 1():343-53. PubMed ID: 17317473
[TBL] [Abstract][Full Text] [Related]
18. Screening Performance for Frailty Among Older Patients With Cancer: A Cross-Sectional Observational Study of Two Approaches.
Okuyama T; Sugano K; Iida S; Ishida T; Kusumoto S; Akechi T
J Natl Compr Canc Netw; 2015 Dec; 13(12):1525-31. PubMed ID: 26656521
[TBL] [Abstract][Full Text] [Related]
19. Identifying an accurate pre-screening tool in geriatric oncology.
Kellen E; Bulens P; Deckx L; Schouten H; Van Dijk M; Verdonck I; Buntinx F
Crit Rev Oncol Hematol; 2010 Sep; 75(3):243-8. PubMed ID: 20060313
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Geriatric Assessment in Men Aged 70 Years or Older with Localised Prostate Cancer Undergoing Radical Radiotherapy.
Osborne GEC; Appleyard SA; Gilbert DC; Jones CI; Lorimer C; Villanueva M; Peasgood E; Robinson A; Nikapota A; Ring A
Clin Oncol (R Coll Radiol); 2017 Sep; 29(9):609-616. PubMed ID: 28592379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
